Exact Mass: 263.0394

Exact Mass Matches: 263.0394

Found 65 metabolites which its exact mass value is equals to given mass value 263.0394, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Epinephrine sulfate

(R)-4-[1-Hydroxy-2-(methylamino)ethyl]-2-benzenediol mono(hydrogen sulphate) (ester)

C9H13NO6S (263.0464)


Epinephrine sulfate is found in human plasma at different levels. Glucuronidation may be an improtant pathway for catecholammine in man at rest or under sympathetic stimulation.(PMID: 6688268) [HMDB] Epinephrine sulfate is found in human plasma at different levels. Glucuronidation may be an improtant pathway for catecholammine in man at rest or under sympathetic stimulation.(PMID: 6688268).

   

N-acetyl-S-(3-oxo-3-carboxy-n-propyl)cysteine

4-{[(2R)-2-carboxy-2-[(1-hydroxyethylidene)amino]ethyl]sulphanyl}-2-oxobutanoic acid

C9H13NO6S (263.0464)


N-acetyl-S-(3-oxo-3-carboxy-n-propyl)cysteine is a cystathione metabolite found in the urine of patients with cystathionuria (PMID 8750604 ). A cystathione metabolite found in the urine of patients with cystathionuria (PMID 8750604 ) [HMDB]

   

Epinephrine 3-sulfate

{2-hydroxy-5-[1-hydroxy-2-(methylamino)ethyl]phenyl}oxidanesulfonic acid

C9H13NO6S (263.0464)


   

2-Chloro-6-(2-methoxyphenyl)nicotinic acid

2-chloro-6-(2-methoxyphenyl)pyridine-3-carboxylic acid

C13H10ClNO3 (263.0349)


   

Epinephrine sulfoconjugate

{2-hydroxy-4-[1-hydroxy-2-(methylamino)ethyl]phenyl}oxidanesulfonic acid

C9H13NO6S (263.0464)


   

Cytidine, 5-chloro-2',3'-dideoxy-3'-fluoro-

4-amino-5-chloro-1-[4-fluoro-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydropyrimidin-2-one

C9H11ClFN3O3 (263.0473)


   

merbarone

4,6-dioxo-N-phenyl-2-sulfanylidene-1,3-diazinane-5-carboxamide

C11H9N3O3S (263.0365)


   

Miloxacin

5-methoxy-8-oxo-2H,5H,8H-[1,3]dioxolo[4,5-g]quinoline-7-carboxylic acid

C12H9NO6 (263.043)


   

Olpadronic acid

[3-(dimethylamino)-1-hydroxy-1-phosphonopropyl]phosphonic acid

C5H15NO7P2 (263.0324)


   

GRK2 Inhibitor

Methyl 5-[2-(5-nitrofuran-2-yl)ethenyl]furan-2-carboxylic acid

C12H9NO6 (263.043)


   
   

Normetanephrine sulfate

Normetanephrine sulfate

C9H13NO6S (263.0464)


   

Adrenaline sulfate

(R)-4-[1-Hydroxy-2-(methylamino)ethyl]-2-benzenediol mono(hydrogen sulfate) (ester)

C9H13NO6S (263.0464)


   

2,3-DCPE

2-[[3-(2,3-dichlorophenoxy)propyl]amino]-ethanol, monohydrochloride

C11H15Cl2NO2 (263.048)


   

6-(5-Chloro-2-Methoxyphenyl)picolinic acid

6-(5-Chloro-2-Methoxyphenyl)picolinic acid

C13H10ClNO3 (263.0349)


   

5-(5-chloro-2-methoxyphenyl)pyridine-3-carboxylic acid

5-(5-chloro-2-methoxyphenyl)pyridine-3-carboxylic acid

C13H10ClNO3 (263.0349)


   

2-(5-chloro-2-methoxyphenyl)pyridine-4-carboxylic acid

2-(5-chloro-2-methoxyphenyl)pyridine-4-carboxylic acid

C13H10ClNO3 (263.0349)


   

5-(chloromethyl)-2,2,8-trimethyl-4H-[1,3]dioxino[4,5-c]pyridine

5-(chloromethyl)-2,2,8-trimethyl-4H-[1,3]dioxino[4,5-c]pyridine

C11H15Cl2NO2 (263.048)


   

1-(2-CHLORO-ACETYL)-3-ISOPROPYL-UREA

1-(2-CHLORO-ACETYL)-3-ISOPROPYL-UREA

C13H10ClNO3 (263.0349)


   

1-(2-CHLORO-ACETYL)-3-PROPYL-UREA

1-(2-CHLORO-ACETYL)-3-PROPYL-UREA

C13H10ClNO3 (263.0349)


   

(2,5-Difluorophenyl)(3-nitrophenyl)methanone

(2,5-Difluorophenyl)(3-nitrophenyl)methanone

C13H7F2NO3 (263.0394)


   

4-chloro-1-nitro-2-phenylmethoxybenzene

4-chloro-1-nitro-2-phenylmethoxybenzene

C13H10ClNO3 (263.0349)


   
   

Methyl 2-amino-4-(3-chlorophenyl)pyrimidine-5-carboxylate

Methyl 2-amino-4-(3-chlorophenyl)pyrimidine-5-carboxylate

C12H10ClN3O2 (263.0462)


   

Methyl 2-amino-4-(4-chlorophenyl)pyrimidine-5-carboxylate

Methyl 2-amino-4-(4-chlorophenyl)pyrimidine-5-carboxylate

C12H10ClN3O2 (263.0462)


   

Methyl 2-amino-4-(2-chlorophenyl)pyrimidine-5-carboxylate

Methyl 2-amino-4-(2-chlorophenyl)pyrimidine-5-carboxylate

C12H10ClN3O2 (263.0462)


   

1,2,4-Triazine-6-carboxylicacid, 5-chloro-3-phenyl-, ethyl ester

1,2,4-Triazine-6-carboxylicacid, 5-chloro-3-phenyl-, ethyl ester

C12H10ClN3O2 (263.0462)


   

2-(4-methylbenzoyl)-3,3-bis(methylsulfanyl)prop-2-enenitrile

2-(4-methylbenzoyl)-3,3-bis(methylsulfanyl)prop-2-enenitrile

C13H13NOS2 (263.0439)


   

2-(3-CHLORO-2,4,5-TRIFLUOROPHENYL)-4,5-DIHYDRO-4,4-DIMETHYLOXAZOLE

2-(3-CHLORO-2,4,5-TRIFLUOROPHENYL)-4,5-DIHYDRO-4,4-DIMETHYLOXAZOLE

C11H9ClF3NO (263.0325)


   

1-(2-Nitro-4-(trifluoromethoxy)phenyl)propan-2-one

1-(2-Nitro-4-(trifluoromethoxy)phenyl)propan-2-one

C10H8F3NO4 (263.0405)


   

Methyl 2-(2-nitro-4-(trifluoromethyl)phenyl)acetate

Methyl 2-(2-nitro-4-(trifluoromethyl)phenyl)acetate

C10H8F3NO4 (263.0405)


   

2-[3-(2,3-Dichlorophenoxy)propylamino]ethanol

2-(3-(2,3-Dichlorophenoxy)propylamino)ethanol hydrochloride

C11H15Cl2NO2 (263.048)


   

4-chloro-3-methoxy-6-phenylpyridine-2-carboxylic acid

4-chloro-3-methoxy-6-phenylpyridine-2-carboxylic acid

C13H10ClNO3 (263.0349)


   

Me2-APD

Olpadronic acid

C5H15NO7P2 (263.0324)


C78281 - Agent Affecting Musculoskeletal System > C67439 - Bone Resorption Inhibitor D050071 - Bone Density Conservation Agents > D004164 - Diphosphonates

   

4H-1-BENZOPYRAN-2-CARBOXYLIC ACID, 6-NITRO-4-OXO-, ETHYL ESTER

4H-1-BENZOPYRAN-2-CARBOXYLIC ACID, 6-NITRO-4-OXO-, ETHYL ESTER

C12H9NO6 (263.043)


   

Ethyl 5-nitro-2-(trifluoromethyl)benzoate

Ethyl 5-nitro-2-(trifluoromethyl)benzoate

C10H8F3NO4 (263.0405)


   

(6-CHLORO-PYRIDAZIN-3-YL)-CARBAMIC ACID BENZYL ESTER

(6-CHLORO-PYRIDAZIN-3-YL)-CARBAMIC ACID BENZYL ESTER

C12H10ClN3O2 (263.0462)


   
   

15-DINITROANTHRAQUINONE97

15-DINITROANTHRAQUINONE97

C10H9N5O2S (263.0477)


   

4-Benzyloxy-3-chloronitrobenzene

4-Benzyloxy-3-chloronitrobenzene

C13H10ClNO3 (263.0349)


   

N-(2,4-difluoro-3-formylphenyl)propane-1-sulfonamide

N-(2,4-difluoro-3-formylphenyl)propane-1-sulfonamide

C10H11F2NO3S (263.0428)


   

4-Chloro-N-(2-hydroxy-1,1-dimethylethyl)benzenesulfonamide

4-Chloro-N-(2-hydroxy-1,1-dimethylethyl)benzenesulfonamide

C10H14ClNO3S (263.0383)


   

1,1-dichloroethene,methyl 2-methylprop-2-enoate,2-methylprop-2-enenitrile

1,1-dichloroethene,methyl 2-methylprop-2-enoate,2-methylprop-2-enenitrile

C11H15Cl2NO2 (263.048)


   

2-chloro-6-phenylmethoxypyridine-4-carboxylic acid

2-chloro-6-phenylmethoxypyridine-4-carboxylic acid

C13H10ClNO3 (263.0349)


   

4-(4-CHLOROPHENYLSULFANYL)PIPERIDINE HYDROCHLORIDE

4-(4-CHLOROPHENYLSULFANYL)PIPERIDINE HYDROCHLORIDE

C11H15Cl2NS (263.0302)


   

Ethyl 4-chlorophenylalaninate hydrochloride (1:1)

Ethyl 4-chlorophenylalaninate hydrochloride (1:1)

C11H15Cl2NO2 (263.048)


   

2-(3-METHYLBENZOYL)-3,3-DI(METHYLTHIO)ACRYLONITRILE

2-(3-METHYLBENZOYL)-3,3-DI(METHYLTHIO)ACRYLONITRILE

C13H13NOS2 (263.0439)


   

3-[(3-methoxyphenyl)sulfonyl]azetidine hydrochloride

3-[(3-methoxyphenyl)sulfonyl]azetidine hydrochloride

C10H14ClNO3S (263.0383)


   

2-chloro-4-(m-tolylamino)pyrimidine-5-carboxylic acid

2-chloro-4-(m-tolylamino)pyrimidine-5-carboxylic acid

C12H10ClN3O2 (263.0462)


   

L-701252

7-chloro-3-(cyclopropanecarbonyl)-4-hydroxyquinolin-2(1H)-one

C13H10ClNO3 (263.0349)


L-701252 is a potent antagonist of glycine site NMDA receptor with an IC50 of 420 nM. L-701252 provides a small degree of neuroprotection in global cerebral ischaemia[1].

   

3-(4-NITRO-1,3-DIOXO-1,3-DIHYDRO-ISOINDOL-2-YL)-PROPIONIC ACID

3-(4-NITRO-1,3-DIOXO-1,3-DIHYDRO-ISOINDOL-2-YL)-PROPIONIC ACID

C11H7N2O6 (263.0304)


   

miloxacin

miloxacin

C12H9NO6 (263.043)


C254 - Anti-Infective Agent > C258 - Antibiotic

   

2-[4-(4-nitrophenyl)-1,3-thiazol-2-yl]acetamide

2-[4-(4-nitrophenyl)-1,3-thiazol-2-yl]acetamide

C11H9N3O3S (263.0365)


   

Ethyl 4-chloro-2-(pyridin-3-yl)pyrimidine-5-carboxylate

Ethyl 4-chloro-2-(pyridin-3-yl)pyrimidine-5-carboxylate

C12H10ClN3O2 (263.0462)


   

BENZENEACETIC ACID, 3-NITRO-5-(TRIFLUOROMETHYL)-, METHYL ESTER

BENZENEACETIC ACID, 3-NITRO-5-(TRIFLUOROMETHYL)-, METHYL ESTER

C10H8F3NO4 (263.0405)


   

merbarone

merbarone

C11H9N3O3S (263.0365)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor D004791 - Enzyme Inhibitors

   

betaARK1 Inhibitor

betaARK1 Inhibitor

C12H9NO6 (263.043)


   

L-Epinephrine (sulfate)

2-hydroxy-4-[(1S)-1-hydroxy-2-methylamino-ethyl]-1-sulfooxy-benzene

C9H13NO6S (263.0464)


   

Cytidine, 5-chloro-2,3-dideoxy-3-fluoro-

Cytidine, 5-chloro-2,3-dideoxy-3-fluoro-

C9H11ClFN3O3 (263.0473)


   

Nitrososulfapyridine

Nitrososulfapyridine

C11H9N3O3S (263.0365)


A pyridine having a 4-nitrosobenzenesulfonamido group at the 2-position.

   

6-Chloro-9-hydroxy-1,3-dimethyl-1,9-dihydro-4H-pyrazolo[3,4-B]quinolin-4-one

6-Chloro-9-hydroxy-1,3-dimethyl-1,9-dihydro-4H-pyrazolo[3,4-B]quinolin-4-one

C12H10ClN3O2 (263.0462)


   

5-Chloropyridin-3-yl 3-methoxybenzoate

5-Chloropyridin-3-yl 3-methoxybenzoate

C13H10ClNO3 (263.0349)


   

5-chloro-2-methoxy-N,N,4-trimethylbenzenesulfonamide

5-chloro-2-methoxy-N,N,4-trimethylbenzenesulfonamide

C10H14ClNO3S (263.0383)


   

Epinephrine sulfate

2-hydroxy-4-[(1S)-1-hydroxy-2-methylamino-ethyl]-1-sulfooxy-benzene

C9H13NO6S (263.0464)


   

N-acetyl-S-(3-oxo-3-carboxy-n-propyl)cysteine

N-acetyl-S-(3-oxo-3-carboxy-n-propyl)cysteine

C9H13NO6S (263.0464)